Results 41 to 50 of about 216,038 (323)
International Journal of Endocrinology, 2020 Background Testosterone replacement therapy (TRT) is commonly used for the treatment of hypogonadism in men, which is often associated with type 2 diabetes mellitus (T2DM) and metabolic syndrome (Mets).
Shuying Li +6 more
semanticscholar +1 more source
Testosterone Replacement Therapy: Long-Term Safety and Efficacy [PDF]
The World Journal of Men's Health, 2017 Recent position statements and guidelines have raised the distinction between a true and false, age-related hypogonadism (HG) or late-onset hypogonadism (LOH).
Giovanni Corona +2 more
doaj +1 more source
Transfusion, 2020 Red blood cells (RBCs) derived from patients who receive testosterone replacement therapy (TRT) may be considered eligible for component production and transfusion.
Keisha L Alexander +7 more
semanticscholar +1 more source
Screening of endocrine organ-specific humoral autoimmunity in 47,XXY Klinefelter's syndrome reveals a significant increase in diabetes-specific immunoreactivity in comparison with healthy control men. [PDF]
, 2015 The aim of this study was to evaluate the frequency of humoral endocrine organ-specific autoimmunity in 47,XXY Klinefelter’s syndrome (KS) by investigating the autoantibody profile specific to type 1 diabetes (T1DM), Addison’s disease (AD), Hashimoto ...
ANZUINI, Antonella +7 more
core +1 more source
Journal of Clinical Endocrinology and Metabolism, 2020 BACKGROUND Obesity and hypogonadism additively contribute to frailty in older men; however, appropriate treatment remains controversial. OBJECTIVE Determine whether testosterone replacement augments the effect of lifestyle therapy on physical function ...
Y. Barnouin +10 more
semanticscholar +1 more source
Testosterone metabolites differentially regulate obesogenesis and fat distribution
Molecular Metabolism, 2021 Objective: Low testosterone in men (hypogonadism) is associated with obesity and type II diabetes. Testosterone replacement therapy has been shown to reverse these effects.
Zachary L. Sebo, Matthew S. Rodeheffer
doaj +1 more source
Androgens and Hypertension in Men and Women: a Unifying View. [PDF]
, 2017 This review was designed to revaluate the androgen role on the mechanisms of hypertension and cardiovascular risks in both men and women. Sex steroids are involved in the regulation of blood pressure, but pathophysiological mechanism is not well ...
Carmina, E. 4. +4 more
core +1 more source
Andrology, 2020 Low testosterone (T) level is considered a marker of poor cardiovascular health. Ten years ago, the Testosterone in Older Men with Mobility Limitations (TOM) trial was discontinued due to a higher number of adverse events in men receiving T compared with
F. Sesti +5 more
semanticscholar +1 more source
Contemporary treatment options for male hypogonadism
Journal of Education, Health and Sport, 2023 Introduction Male hypogonadism is a disease in which testicular function is impaired. Its symptoms are due to testosterone deficiency and most of them show low specificity.
Paweł Sojka +9 more
doaj +1 more source
Testosterone Deficiency, Cardiac Health, and Older Men
International Journal of Endocrinology, 2014 Low levels of testosterone are manifested by erectile dysfunction, reduced sexual desire, and loss of morning erections with increasing numbers of men are being diagnosed and require treatment.
G. Hackett, M. Kirby, A. J. Sinclair
doaj +1 more source